This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperekplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known.
Gephyrin is a 93kDa multi-functional protein that is a component of the postsynaptic protein network of inhibitory synapses. It consists of 3 domains: N terminal G domain, C terminal E domain, and a large unstructured linker domain which connects the two. Although there are structures available for trimeric G and dimeric E domains, there is no structure available for the full length protein, which may be due to the large unstructured region which makes the protein hard to crystallize. But a recent study of the full length gephyrin by small-angle X-ray scattering shows that it predominantly forms trimers, and that because of its long linker region, it can exist in either a compact state or either of two extended states.
Positive antibody staining for gephyrin at a synapse is most of the time consistent with the presence of glycine and/or GABAA receptors. Nevertheless, some exceptions can occur like in neurons of Dorsal Root Ganglions where gephyrin is absent despite the presence of GABAA receptors. Gephyrin is considered a major scaffolding protein at inhibitory synapses, analogous in its function to that of PSD-95 at glutamatergic synapses. Gephyrin was identified by its interaction with the glycine receptor, the main receptor protein of inhibitory synapses in the spinal cord and brainstem. In addition to its interaction with the glycine receptor, recent publications have shown that gephyrin also interacts with the intracellular loop between the transmembrane helices TM3 and TM4 of alpha and beta subunits of the GABAA receptor.
Gephyrin displaces GABA receptors from the GABARAP/P130 complex, then brings the receptors to the synapse. Once at the synapse, the protein binds to collybistin and neuroligin 2. In cells, gephyrin appears to form oligomers of at least three subunits. Several splice variants have been described that prevent this oligomerization without influencing the affinity for receptors. They nevertheless affect the composition of inhibitory synapses and can even play a role in diseases like epilepsy.
Humans with temporal lobe epilepsy have been found to have abnormally low levels of gephyrin in their temporal lobes. In animal models, a total lack of gephyrin results in stiff muscles and death immediately after birth. Stiff muscles are also a symptom of startle disease, that can be caused by a mutation in the gephyrin gene. And if a person produces auto-antibodies against gephyrin, this can even result in stiff person syndrome.
^Prior P, Schmitt B, Grenningloh G, Pribilla I, Multhaup G, Beyreuther K et al. (Jul 1992). "Primary structure and alternative splice variants of gephyrin, a putative glycine receptor-tubulin linker protein". Neuron8 (6): 1161–70. doi:10.1016/0896-6273(92)90136-2. PMID1319186.
^ abSabatini DM, Barrow RK, Blackshaw S, Burnett PE, Lai MM, Field ME et al. (Jun 1999). "Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling". Science284 (5417): 1161–4. doi:10.1126/science.284.5417.1161. PMID10325225.
^ abLorenzo LE, Godin AG, Wang F, St-Louis M, Carbonetto S, Wiseman PW et al. (June 2014). "Gephyrin Clusters Are Absent from Small Diameter Primary Afferent Terminals Despite the Presence of GABAA Receptors". J. Neurosci.34 (24): 8300–17. doi:10.1523/JNEUROSCI.0159-14.2014. PMID24920633.
^Sander B, Tria G, Shkumatov AV, Kim EY, Grossmann JG, Tessmer I et al. (Oct 2013). "Structural characterization of gephyrin by AFM and SAXS reveals a mixture of compact and extended states.". Acta crystallographica. Section D, Biological crystallography69 (Pt 10): 2050–60. doi:10.1107/S0907444913018714. PMID24100323.
^Giesemann T, Schwarz G, Nawrotzki R, Berhörster K, Rothkegel M, Schlüter K et al. (September 2003). "Complex formation between the postsynaptic scaffolding protein gephyrin, profilin, and Mena: a possible link to the microfilament system". J. Neurosci.23 (23): 8330–9. PMID12967995.
^Poulopoulos A, Aramuni G, Meyer G, Soykan T, Hoon M, Papadopoulos T et al. (September 2009). "Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin". Neuron63 (5): 628–42. doi:10.1016/j.neuron.2009.08.023. PMID19755106.
^Reiss J, Johnson JL (June 2003). "Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH". Hum. Mutat.21 (6): 569–76. doi:10.1002/humu.10223. PMID12754701.
^Fang M, Shen L, Yin H, Pan YM, Wang L, Chen D et al. (October 2011). "Downregulation of gephyrin in temporal lobe epilepsy neurons in humans and a rat model". Synapse65 (10): 1006–14. doi:10.1002/syn.20928. PMID21404332.
Reiss J, Johnson JL (2003). "Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH". Hum. Mutat.21 (6): 569–76. doi:10.1002/humu.10223. PMID12754701.
Kirsch J, Langosch D, Prior P, Littauer UZ, Schmitt B, Betz H (1991). "The 93-kDa glycine receptor-associated protein binds to tubulin". J. Biol. Chem.266 (33): 22242–5. PMID1657993.
Lorenzo LE, Barbe A, Bras H (March 2004). "Mapping and quantitative analysis of gephyrin cytoplasmic trafficking pathways in motoneurons, using an optimized Transmission Electron Microscopy Color Imaging (TEMCI) procedure". Journal of Neurocytology - Springer33 (2): 241–9. doi:10.1023/B:NEUR.0000030699.74642.7d. PMID15322382.
Mammoto A, Sasaki T, Asakura T, Hotta I, Imamura H, Takahashi K et al. (1998). "Interactions of drebrin and gephyrin with profilin". Biochem. Biophys. Res. Commun.243 (1): 86–9. doi:10.1006/bbrc.1997.8068. PMID9473484.
Nagase T, Kikuno R, Ishikawa KI, Hirosawa M, Ohara O (2000). "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro". DNA Res.7 (1): 65–73. doi:10.1093/dnares/7.1.65. PMID10718198.
Schwarz G, Schrader N, Mendel RR, Hecht HJ, Schindelin H (2001). "Crystal structures of human gephyrin and plant Cnx1 G domains: comparative analysis and functional implications". J. Mol. Biol.312 (2): 405–18. doi:10.1006/jmbi.2001.4952. PMID11554796.
Grosskreutz Y, Hermann A, Kins S, Fuhrmann JC, Betz H, Kneussel M (2002). "Identification of a gephyrin-binding motif in the GDP/GTP exchange factor collybistin". Biol. Chem.382 (10): 1455–62. doi:10.1515/BC.2001.179. PMID11727829.
Fuhrmann JC, Kins S, Rostaing P, El Far O, Kirsch J, Sheng M et al. (2002). "Gephyrin interacts with Dynein light chains 1 and 2, components of motor protein complexes". J. Neurosci.22 (13): 5393–402. PMID12097491.
Waldvogel HJ, Baer K, Snell RG, During MJ, Faull RL, Rees MI (2003). "Distribution of gephyrin in the human brain: an immunohistochemical analysis". Neuroscience116 (1): 145–56. doi:10.1016/S0306-4522(02)00550-X. PMID12535948.